Firefly Neuroscience (AIFF) Accumulated Expenses (2010 - 2026)

Firefly Neuroscience has reported Accumulated Expenses for 16 years, with the latest figure at $524000.0 in Q2 2026.

• On a quarterly basis, Accumulated Expenses fell 1.5% year-over-year to $524000.0 in Q2 2026; TTM through Jun 2026 was $524000.0, a 1.5% decrease from a year earlier, with the FY2025 full-year figure at $766000.0, down 52.89% from the prior year.
• Accumulated Expenses was $524000.0 for Q2 2026 at Firefly Neuroscience, up from $453000.0 in the prior quarter.
• The five-year high for Accumulated Expenses was $1.6 million in Q4 2024, with the low at $453000.0 in Q1 2026.
• Average Accumulated Expenses over 5 years is $719126.2, with a median of $613631.5 recorded in 2022.
• The sharpest annual moves came in 2024 and 2026: Accumulated Expenses soared 164.06% in 2024, then sank 60.81% in 2026.
• Over 5 years, Accumulated Expenses stood at $676796.0 in 2022, then fell by 9.02% to $615766.0 in 2023, then jumped by 164.06% to $1.6 million in 2024, then tumbled by 52.89% to $766000.0 in 2025, then slumped by 31.59% to $524000.0 in 2026.
• The last three Accumulated Expenses figures came in at $524000.0 (Q2 2026), $453000.0 (Q1 2026), and $766000.0 (Q4 2025), per Business Quant data.